Acebrophylline (SR), Fexofenadine Hydrochloride & Montelukast Sodium Tablets
KIMONTE-LC TABLETS
Montelukast 10 mg
Levocetirizine 5 mg
Clinical Indications for KIMONTE-LC:
- An orally active, potent, selective leukotriene receptor antagonist.
- Helps in management of asthma / seasonal allergies.
- The third generation Fexofenadine is effective in reducing the total symptom score of allergic rhinitis including blocked nose and is considered safe for pediatric patients as young as 6 years of age.
- New generation airway mucus regulator.
- Reduces the use of short acting B2 agonist inhalers.
- Better anti-inflammatory effects.